Telesis Bio Inc (TBIO)
4.35
-0.27
(-5.90%)
USD |
NASDAQ |
May 16, 16:00
4.33
-0.02
(-0.46%)
After-Hours: 20:00
Telesis Bio Enterprise Value: 26.79M for May 16, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 16, 2024 | 26.79M |
| May 15, 2024 | 27.24M |
| May 14, 2024 | 26.56M |
| May 13, 2024 | 26.45M |
| May 10, 2024 | 28.07M |
| May 09, 2024 | 29.61M |
| May 08, 2024 | 29.17M |
| May 07, 2024 | 28.72M |
| May 06, 2024 | 29.74M |
| May 03, 2024 | 29.45M |
| May 02, 2024 | 30.17M |
| May 01, 2024 | 30.22M |
| April 30, 2024 | 30.38M |
| April 29, 2024 | 29.73M |
| April 26, 2024 | 29.10M |
| April 25, 2024 | 29.19M |
| April 24, 2024 | 29.18M |
| April 23, 2024 | 29.25M |
| April 22, 2024 | 29.00M |
| April 19, 2024 | 28.81M |
| April 18, 2024 | 29.48M |
| April 17, 2024 | 30.95M |
| April 16, 2024 | 30.57M |
| April 15, 2024 | 30.88M |
| April 12, 2024 | 31.85M |
| Date | Value |
|---|---|
| April 11, 2024 | 32.64M |
| April 10, 2024 | 32.35M |
| April 09, 2024 | 32.46M |
| April 08, 2024 | 32.48M |
| April 05, 2024 | 32.76M |
| April 04, 2024 | 33.39M |
| April 03, 2024 | 33.87M |
| April 02, 2024 | 32.71M |
| April 01, 2024 | 32.62M |
| March 31, 2024 | 32.76M |
| March 28, 2024 | 28.66M |
| March 27, 2024 | 28.94M |
| March 26, 2024 | 28.58M |
| March 25, 2024 | 28.94M |
| March 22, 2024 | 28.79M |
| March 21, 2024 | 29.41M |
| March 20, 2024 | 29.03M |
| March 19, 2024 | 31.62M |
| March 18, 2024 | 31.65M |
| March 15, 2024 | 31.01M |
| March 14, 2024 | 30.87M |
| March 13, 2024 | 31.74M |
| March 12, 2024 | 31.74M |
| March 11, 2024 | 31.40M |
| March 08, 2024 | 31.92M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-5.537M
Minimum
Jun 29 2022
594.55M
Maximum
Jun 22 2021
85.51M
Average
37.02M
Median
Oct 03 2023
Enterprise Value Benchmarks
| Ainos Inc | 10.47M |
| OpGen Inc | 13.81M |
| Zomedica Corp | 97.64M |
| LENSAR Inc | 29.50M |
| Eargo Inc (DELISTED) | -- |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -8.637M |
| Revenue (Quarterly) | 3.44M |
| Total Expenses (Quarterly) | 11.96M |
| EPS Diluted (Quarterly) | -5.52 |
| Gross Profit Margin (Quarterly) | 42.03% |
| Profit Margin (Quarterly) | -251.1% |
| Earnings Yield | -648.3% |
| Normalized Earnings Yield | -526.31 |